After drug‑coated balloon (DCB) angioplasty without stent placement, what dual antiplatelet therapy (aspirin and clopidogrel) should be prescribed and how should it be managed before elective surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

DAPT After Drug-Coated Balloon Angioplasty Without Stent

After drug-coated balloon (DCB) angioplasty without stent placement, prescribe aspirin plus clopidogrel (or ticagrelor) for 1 month, then continue aspirin alone indefinitely. This shorter DAPT duration is safe because DCBs leave no permanent foreign material requiring prolonged endothelialization, unlike stents 1, 2.

Initial DAPT Regimen

Start dual antiplatelet therapy immediately after DCB angioplasty:

  • Aspirin 75-100 mg daily (continue indefinitely) 3
  • Plus clopidogrel 75 mg daily (after 300 mg loading dose if acute coronary syndrome) 4
  • Or ticagrelor if acute coronary syndrome and no contraindications 3

Add a proton pump inhibitor (preferably pantoprazole or rabeprazole over omeprazole/esomeprazole to avoid CYP2C19 interaction with clopidogrel) 3, 4.

Duration: 1 Month is Sufficient

The critical distinction from stent-based PCI is that DCB-only angioplasty requires only 1 month of DAPT, not 6-12 months. Real-world data from 303 patients showed zero cases of lesion thrombosis, target vessel MI, or cardiac death at 6 months with just 1-month DAPT after elective DCB 1. The recent REC-CAGEFREE II trial (1,948 patients) confirmed that even stepwise de-escalation starting at 1 month was non-inferior to standard 12-month DAPT, with significantly less bleeding 2.

After 1 month, transition to:

  • Aspirin monotherapy 75-100 mg daily (lifelong) 3

Perioperative Management Before Elective Surgery

The timing depends on when surgery occurs relative to DCB angioplasty:

Within First Month After DCB (High-Risk Period)

Do not perform elective surgery during the first month after DCB if DAPT must be discontinued. This mirrors the recommendation for bare-metal stents 5. If surgery cannot be delayed:

  • Continue both aspirin and clopidogrel perioperatively unless bleeding risk in a closed space (intracranial, spinal canal, posterior eye chamber) 3, 5
  • The thrombotic risk of stopping DAPT overwhelms surgical bleeding risk in most procedures 6, 7
  • Restart the P2Y12 inhibitor within 12-24 hours postoperatively 5, 7

After 1 Month (Lower-Risk Period)

Once past the 1-month mark and already on aspirin monotherapy:

  • Continue aspirin perioperatively for most surgeries 3, 5
  • Only stop aspirin for surgeries in closed spaces or those with catastrophic bleeding potential 6, 7
  • Resume aspirin as soon as hemostasis is achieved 3

Timing for Elective Surgery Requiring DAPT Interruption

If elective surgery absolutely requires stopping both antiplatelet agents:

  • Wait minimum 14 days after DCB angioplasty before stopping aspirin 5
  • Ideally wait 30 days to complete the recommended DAPT course 1
  • Stop clopidogrel 5 days before surgery (7-10 days for prasugrel, 3-5 days for ticagrelor) to allow platelet function recovery 4, 8
  • Continue aspirin if bleeding risk permits 3, 5

Critical Pitfalls to Avoid

Never stop DAPT in the first month after DCB for elective surgery—the thrombotic risk is unacceptable 5. The ESC guideline explicitly states elective surgery should not be performed within 30 days of bare-metal stent or balloon angioplasty if antiplatelet therapy must be discontinued 3, 5.

Do not use heparin or LMWH as "bridge therapy" when stopping antiplatelet agents—this provides zero protection against coronary thrombosis 7.

Avoid omeprazole and esomeprazole with clopidogrel due to significant CYP2C19 inhibition that reduces antiplatelet efficacy; use pantoprazole or rabeprazole instead 3, 4.

Why DCB Differs from Stents

The shorter DAPT duration after DCB (1 month vs. 6-12 months for drug-eluting stents) is justified because DCBs deliver antiproliferative drugs without leaving permanent metal scaffolding 9, 10. Without foreign material requiring endothelialization, the thrombotic risk drops substantially after the acute injury phase (first month) 1, 2. This makes DCB particularly attractive for patients at high bleeding risk who need surgery 9, 2.

References

Research

Duration of dual antiplatelet therapy in elective drug-coated balloon angioplasty.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2020

Research

Perioperative antiplatelet therapy.

American family physician, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.